Detalhe da pesquisa
1.
Patient Preferences for Treatment Attributes in Inflammatory Bowel Disease: Results From a Large Survey Across Seven European Countries Using a Discrete Choice Experiment.
Inflamm Bowel Dis
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38503480
2.
Prime Time Was Yesterday for Patient-reported Outcomes in Daily Care of Patients With Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 16(11): 1839, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30343866
3.
Patient-reported Outcomes and Disability Are Associated with Histological Disease Activity in Patients with Ulcerative Colitis: Results from the APOLLO Study.
J Crohns Colitis
; 17(7): 1046-1054, 2023 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708189
4.
Introduction of Subcutaneous Infliximab CT-P13 and Vedolizumab in Clinical Practice: A Multi-Stakeholder Position Statement Highlighting the Need for Post-Marketing Studies.
J Crohns Colitis
; 16(7): 1059-1069, 2022 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078228
5.
Ultra-proactive Therapeutic Drug Monitoring of Infliximab Based on Point of Care Testing in Inflammatory Bowel Disease: Results of a Pragmatic Trial.
J Crohns Colitis
; 16(2): 199-206, 2022 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297099
6.
Letter to the Editor: Feasibility and Efficiency of an E-Health Preadmission Assessment System for Intravenous Therapy in Inflammatory Bowel Disease.
Inflamm Bowel Dis
; 26(2): e11-e12, 2020 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31793628
7.
Genetic association and functional role of Crohn disease risk alleles involved in microbial sensing, autophagy, and endoplasmic reticulum (ER) stress.
Autophagy
; 9(12): 2046-55, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24247223